aspirin, acetaminophen, ibuprofen, naproxen, celecoxib, rofecoxib
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedAbout aspirin, acetaminophen, ibuprofen, naproxen, celecoxib, rofecoxib
aspirin, acetaminophen, ibuprofen, naproxen, celecoxib, rofecoxib is a approved stage product being developed by Johnson & Johnson for Analgesics. The current trial status is completed. This product is registered under clinical trial identifier NCT00261586. Target conditions include Analgesics.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00261586 | Approved | Completed |